Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.
Identifieur interne : 000297 ( Main/Exploration ); précédent : 000296; suivant : 000298Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.
Auteurs : Luca Quartuccio [Italie] ; Luca Semerano [France] ; Maurizio Benucci [Italie] ; Marie-Christophe Boissier [France] ; Salvatore De Vita [Italie]Source :
- Joint bone spine [ 1778-7254 ] ; 2020.
Descripteurs français
- KwdFr :
- Activation du complément (MeSH), Betacoronavirus (pathogénicité), Cytokines (métabolisme), Fibromyalgie (virologie), Humains (MeSH), Infections à coronavirus (complications), Infections à coronavirus (immunologie), Infections à coronavirus (traitement médicamenteux), Inflammation (virologie), Pandémies (MeSH), Pneumopathie virale (complications), Pneumopathie virale (immunologie), Pneumopathie virale (traitement médicamenteux), Poumon (anatomopathologie), Poumon (immunologie), Syndrome respiratoire aigu sévère (immunologie).
- MESH :
- anatomopathologie : Poumon.
- immunologie : Infections à coronavirus, Pneumopathie virale, Poumon, Syndrome respiratoire aigu sévère.
- métabolisme : Cytokines, Infections à coronavirus, Pneumopathie virale.
- pathogénicité : Betacoronavirus.
- traitement médicamenteux : Infections à coronavirus, Pneumopathie virale.
- virologie : Fibromyalgie, Inflammation.
- Activation du complément, Humains, Pandémies.
English descriptors
- KwdEn :
- Betacoronavirus (pathogenicity), Complement Activation (MeSH), Coronavirus Infections (complications), Coronavirus Infections (drug therapy), Coronavirus Infections (immunology), Cytokines (metabolism), Fibromyalgia (virology), Humans (MeSH), Inflammation (virology), Lung (immunology), Lung (pathology), Pandemics (MeSH), Pneumonia, Viral (complications), Pneumonia, Viral (drug therapy), Pneumonia, Viral (immunology), Severe Acute Respiratory Syndrome (immunology).
- MESH :
- chemical , metabolism : Cytokines.
- complications : Coronavirus Infections, Pneumonia, Viral.
- drug therapy : Coronavirus Infections, Pneumonia, Viral.
- immunology : Coronavirus Infections, Lung, Pneumonia, Viral, Severe Acute Respiratory Syndrome.
- pathogenicity : Betacoronavirus.
- pathology : Lung.
- virology : Fibromyalgia, Inflammation.
- Complement Activation, Humans, Pandemics.
DOI: 10.1016/j.jbspin.2020.03.011
PubMed: 32321634
PubMed Central: PMC7167227
Affiliations:
Links toward previous steps (curation, corpus...)
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.</title><author><name sortKey="Quartuccio, Luca" sort="Quartuccio, Luca" uniqKey="Quartuccio L" first="Luca" last="Quartuccio">Luca Quartuccio</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy. Electronic address: luca.quartuccio@asufc.sanita.fvg.it.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine</wicri:regionArea><wicri:noRegion>Udine</wicri:noRegion></affiliation></author><author><name sortKey="Semerano, Luca" sort="Semerano, Luca" uniqKey="Semerano L" first="Luca" last="Semerano">Luca Semerano</name><affiliation wicri:level="3"><nlm:affiliation>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="Benucci, Maurizio" sort="Benucci, Maurizio" uniqKey="Benucci M" first="Maurizio" last="Benucci">Maurizio Benucci</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Rheumatology Unit, S. Giovanni di Dio Hospital, Florence</wicri:regionArea><wicri:noRegion>Florence</wicri:noRegion></affiliation></author><author><name sortKey="Boissier, Marie Christophe" sort="Boissier, Marie Christophe" uniqKey="Boissier M" first="Marie-Christophe" last="Boissier">Marie-Christophe Boissier</name><affiliation wicri:level="3"><nlm:affiliation>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="De Vita, Salvatore" sort="De Vita, Salvatore" uniqKey="De Vita S" first="Salvatore" last="De Vita">Salvatore De Vita</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine</wicri:regionArea><wicri:noRegion>Udine</wicri:noRegion></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2020">2020</date><idno type="RBID">pubmed:32321634</idno><idno type="pmid">32321634</idno><idno type="doi">10.1016/j.jbspin.2020.03.011</idno><idno type="pmc">PMC7167227</idno><idno type="wicri:Area/Main/Corpus">001634</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">001634</idno><idno type="wicri:Area/Main/Curation">001634</idno><idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">001634</idno><idno type="wicri:Area/Main/Exploration">001634</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.</title><author><name sortKey="Quartuccio, Luca" sort="Quartuccio, Luca" uniqKey="Quartuccio L" first="Luca" last="Quartuccio">Luca Quartuccio</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy. Electronic address: luca.quartuccio@asufc.sanita.fvg.it.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine</wicri:regionArea><wicri:noRegion>Udine</wicri:noRegion></affiliation></author><author><name sortKey="Semerano, Luca" sort="Semerano, Luca" uniqKey="Semerano L" first="Luca" last="Semerano">Luca Semerano</name><affiliation wicri:level="3"><nlm:affiliation>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="Benucci, Maurizio" sort="Benucci, Maurizio" uniqKey="Benucci M" first="Maurizio" last="Benucci">Maurizio Benucci</name><affiliation wicri:level="1"><nlm:affiliation>Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Rheumatology Unit, S. Giovanni di Dio Hospital, Florence</wicri:regionArea><wicri:noRegion>Florence</wicri:noRegion></affiliation></author><author><name sortKey="Boissier, Marie Christophe" sort="Boissier, Marie Christophe" uniqKey="Boissier M" first="Marie-Christophe" last="Boissier">Marie-Christophe Boissier</name><affiliation wicri:level="3"><nlm:affiliation>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.</nlm:affiliation><country xml:lang="fr">France</country><wicri:regionArea>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny</wicri:regionArea><placeName><region type="region">Île-de-France</region><region type="old region">Île-de-France</region><settlement type="city">Bobigny</settlement></placeName></affiliation></author><author><name sortKey="De Vita, Salvatore" sort="De Vita, Salvatore" uniqKey="De Vita S" first="Salvatore" last="De Vita">Salvatore De Vita</name><affiliation wicri:level="1"><nlm:affiliation>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.</nlm:affiliation><country xml:lang="fr">Italie</country><wicri:regionArea>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine</wicri:regionArea><wicri:noRegion>Udine</wicri:noRegion></affiliation></author></analytic><series><title level="j">Joint bone spine</title><idno type="eISSN">1778-7254</idno><imprint><date when="2020" type="published">2020</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (pathogenicity)</term><term>Complement Activation (MeSH)</term><term>Coronavirus Infections (complications)</term><term>Coronavirus Infections (drug therapy)</term><term>Coronavirus Infections (immunology)</term><term>Cytokines (metabolism)</term><term>Fibromyalgia (virology)</term><term>Humans (MeSH)</term><term>Inflammation (virology)</term><term>Lung (immunology)</term><term>Lung (pathology)</term><term>Pandemics (MeSH)</term><term>Pneumonia, Viral (complications)</term><term>Pneumonia, Viral (drug therapy)</term><term>Pneumonia, Viral (immunology)</term><term>Severe Acute Respiratory Syndrome (immunology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Activation du complément (MeSH)</term><term>Betacoronavirus (pathogénicité)</term><term>Cytokines (métabolisme)</term><term>Fibromyalgie (virologie)</term><term>Humains (MeSH)</term><term>Infections à coronavirus (complications)</term><term>Infections à coronavirus (immunologie)</term><term>Infections à coronavirus (traitement médicamenteux)</term><term>Inflammation (virologie)</term><term>Pandémies (MeSH)</term><term>Pneumopathie virale (complications)</term><term>Pneumopathie virale (immunologie)</term><term>Pneumopathie virale (traitement médicamenteux)</term><term>Poumon (anatomopathologie)</term><term>Poumon (immunologie)</term><term>Syndrome respiratoire aigu sévère (immunologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Cytokines</term></keywords><keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Poumon</term></keywords><keywords scheme="MESH" qualifier="complications" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Coronavirus Infections</term><term>Pneumonia, Viral</term></keywords><keywords scheme="MESH" qualifier="immunologie" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term><term>Poumon</term><term>Syndrome respiratoire aigu sévère</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>Coronavirus Infections</term><term>Lung</term><term>Pneumonia, Viral</term><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Cytokines</term><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="pathogenicity" xml:lang="en"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathogénicité" xml:lang="fr"><term>Betacoronavirus</term></keywords><keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Lung</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Infections à coronavirus</term><term>Pneumopathie virale</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Fibromyalgie</term><term>Inflammation</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Fibromyalgia</term><term>Inflammation</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Complement Activation</term><term>Humans</term><term>Pandemics</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Activation du complément</term><term>Humains</term><term>Pandémies</term></keywords></textClass></profileDesc></teiHeader></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32321634</PMID><DateCompleted><Year>2020</Year><Month>04</Month><Day>27</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>27</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1778-7254</ISSN><JournalIssue CitedMedium="Internet"><Volume>87</Volume><Issue>3</Issue><PubDate><Year>2020</Year><Month>05</Month></PubDate></JournalIssue><Title>Joint bone spine</Title><ISOAbbreviation>Joint Bone Spine</ISOAbbreviation></Journal><ArticleTitle>Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.</ArticleTitle><Pagination><MedlinePgn>191-193</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">S1297-319X(20)30047-6</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jbspin.2020.03.011</ELocationID><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Quartuccio</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy. Electronic address: luca.quartuccio@asufc.sanita.fvg.it.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Semerano</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Benucci</LastName><ForeName>Maurizio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rheumatology Unit, S. Giovanni di Dio Hospital, Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boissier</LastName><ForeName>Marie-Christophe</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Université Sorbonne Paris Nord, Li2P, Bobigny, France; Inserm U1125, Bobigny, France; Assistance Publique-Hôpitaux de Paris, GH HUPSSD, Rheumatology Department, Bobigny, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Vita</LastName><ForeName>Salvatore</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Clinic of Rheumatology, Department of Medicine (DAME), ASUFC, University of Udine, Udine, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016421">Editorial</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Joint Bone Spine</MedlineTA><NlmUniqueID>100938016</NlmUniqueID><ISSNLinking>1297-319X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical></ChemicalList><SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName><SupplMeshName Type="Protocol" UI="C000705127">COVID-19 drug treatment</SupplMeshName><SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Rev Rhum Ed Fr. 2020 May;87(3):146-149</RefSource><PMID Version="1">32355445</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName><QualifierName UI="Q000472" MajorTopicYN="Y">pathogenicity</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003167" MajorTopicYN="Y">Complement Activation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005356" MajorTopicYN="N">Fibromyalgia</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008168" MajorTopicYN="N">Lung</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="Y">COVID-19</Keyword><Keyword MajorTopicYN="Y">Coronavirus</Keyword><Keyword MajorTopicYN="Y">Cytokine</Keyword><Keyword MajorTopicYN="Y">IL-6</Keyword><Keyword MajorTopicYN="Y">SARS</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>4</Month><Day>28</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32321634</ArticleId><ArticleId IdType="pii">S1297-319X(20)30047-6</ArticleId><ArticleId IdType="doi">10.1016/j.jbspin.2020.03.011</ArticleId><ArticleId IdType="pmc">PMC7167227</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Antiviral Res. 2017 Jul;143:142-150</Citation><ArticleIdList><ArticleId IdType="pubmed">28390872</ArticleId></ArticleIdList></Reference><Reference><Citation>J Antimicrob Chemother. 2020 Mar 20;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32196083</ArticleId></ArticleIdList></Reference><Reference><Citation>Arthritis Rheum. 2012 Mar;64(3):843-53</Citation><ArticleIdList><ArticleId IdType="pubmed">22147661</ArticleId></ArticleIdList></Reference><Reference><Citation>Cell Biosci. 2020 Mar 16;10:40</Citation><ArticleIdList><ArticleId IdType="pubmed">32190290</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet Respir Med. 2020 Mar 5;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32145830</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2003 May 24;361(9371):1773-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12781536</ArticleId></ArticleIdList></Reference><Reference><Citation>Clin Exp Immunol. 2004 Apr;136(1):95-103</Citation><ArticleIdList><ArticleId IdType="pubmed">15030519</ArticleId></ArticleIdList></Reference><Reference><Citation>J Biol Regul Homeost Agents. 2020 Mar 14;34(2):</Citation><ArticleIdList><ArticleId IdType="pubmed">32171193</ArticleId></ArticleIdList></Reference><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1953-66</Citation><ArticleIdList><ArticleId IdType="pubmed">12690092</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2018 Apr 24;7(1):77</Citation><ArticleIdList><ArticleId IdType="pubmed">29691378</ArticleId></ArticleIdList></Reference><Reference><Citation>Am J Respir Cell Mol Biol. 2013 Aug;49(2):221-30</Citation><ArticleIdList><ArticleId IdType="pubmed">23526211</ArticleId></ArticleIdList></Reference><Reference><Citation>J Med Virol. 2005 Feb;75(2):185-94</Citation><ArticleIdList><ArticleId IdType="pubmed">15602737</ArticleId></ArticleIdList></Reference><Reference><Citation>Emerg Microbes Infect. 2015 May;4(5):e28</Citation><ArticleIdList><ArticleId IdType="pubmed">26060601</ArticleId></ArticleIdList></Reference><Reference><Citation>Nat Med. 2018 Jun;24(6):731-738</Citation><ArticleIdList><ArticleId IdType="pubmed">29808005</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhonghua Bing Li Xue Za Zhi. 2020 Mar 15;49(0):E009</Citation><ArticleIdList><ArticleId IdType="pubmed">32172546</ArticleId></ArticleIdList></Reference><Reference><Citation>Int J Antimicrob Agents. 2020 Mar 19;:105946</Citation><ArticleIdList><ArticleId IdType="pubmed">32199877</ArticleId></ArticleIdList></Reference><Reference><Citation>Lancet. 2020 Feb 15;395(10223):e30-e31</Citation><ArticleIdList><ArticleId IdType="pubmed">32032529</ArticleId></ArticleIdList></Reference><Reference><Citation>Oncologist. 2018 Aug;23(8):943-947</Citation><ArticleIdList><ArticleId IdType="pubmed">29622697</ArticleId></ArticleIdList></Reference><Reference><Citation>Front Microbiol. 2019 Jan 29;10:50</Citation><ArticleIdList><ArticleId IdType="pubmed">30761102</ArticleId></ArticleIdList></Reference><Reference><Citation>JAMA. 2020 Feb 7;:</Citation><ArticleIdList><ArticleId IdType="pubmed">32031570</ArticleId></ArticleIdList></Reference><Reference><Citation>Histopathology. 2004 Aug;45(2):119-24</Citation><ArticleIdList><ArticleId IdType="pubmed">15279629</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed><affiliations><list><country><li>France</li><li>Italie</li></country><region><li>Île-de-France</li></region><settlement><li>Bobigny</li></settlement></list><tree><country name="Italie"><noRegion><name sortKey="Quartuccio, Luca" sort="Quartuccio, Luca" uniqKey="Quartuccio L" first="Luca" last="Quartuccio">Luca Quartuccio</name></noRegion><name sortKey="Benucci, Maurizio" sort="Benucci, Maurizio" uniqKey="Benucci M" first="Maurizio" last="Benucci">Maurizio Benucci</name><name sortKey="De Vita, Salvatore" sort="De Vita, Salvatore" uniqKey="De Vita S" first="Salvatore" last="De Vita">Salvatore De Vita</name></country><country name="France"><region name="Île-de-France"><name sortKey="Semerano, Luca" sort="Semerano, Luca" uniqKey="Semerano L" first="Luca" last="Semerano">Luca Semerano</name></region><name sortKey="Boissier, Marie Christophe" sort="Boissier, Marie Christophe" uniqKey="Boissier M" first="Marie-Christophe" last="Boissier">Marie-Christophe Boissier</name></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000297 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000297 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= CovidFranceV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:32321634
|texte= Urgent avenues in the treatment of COVID-19: Targeting downstream inflammation to prevent catastrophic syndrome.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:32321634" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a CovidFranceV1
| This area was generated with Dilib version V0.6.37. |  |